Latest News about PharmaCann
Recent news which mentions PharmaCann
THC Potency Isn't Everything: Here Are Some Strategies To Deal With Industry Challenges
October 25, 2024
From Benzinga
PharmaCann Wins Rooster Food Fight for Best Edibles
January 03, 2024
From Benzinga
New York Will Get 12 New Weed Dispensaries, Ending 2023 With More Than 35 Adult-Use Stores Open
December 15, 2023
From Benzinga
From Benzinga
From Benzinga
Turning Over A New Leaf In New York? Cannabis Dispensaries Await Movement After Crucial Lawsuit Settlement
November 27, 2023
From Benzinga
Cannabis Dispensaries Gear Up for Green Wednesday
November 14, 2023
From Benzinga
Consumers Prefer Their Edibles High in THC
October 04, 2023
From Benzinga
Inclusion Ignites Illinois Marijuana Industry: New Ventures Rise As Benzinga's Cannabis Conference Hits Chicago
August 08, 2023
From Benzinga
XS Financial Provides $7.6M CAPEX Financing To PharmaCann
August 07, 2023
Tickers
XSHLF
From Benzinga
Marijuana Retailer Takes Legal Action Against Labor Requirement For Cannabis Sales In Rhode Island
July 11, 2023
From Benzinga
Lifelong Teamster On How Cannabis Workers Are Rejecting 'Churn-And-Burn-Model' Toward Prosperous Careers
May 19, 2023
Tickers
GTBIF
From Benzinga
From Benzinga
Second Round: New York MSO Coalition Targets Gov. Kathy Hochul Over Lax Cannabis Enforcement
March 31, 2023
From Benzinga
From Benzinga
Cannabis Co. Nabs Sponsorship Deal With American Hockey League Champs, Chicago Wolves
November 17, 2022
From Benzinga
From Benzinga
EXCLUSIVE: How To Conquer The Midwest? 4Front, Pharmacann & Marimed Execs Discuss At Benzinga Cannabis Conference
September 14, 2022
From Benzinga
From Benzinga
From Benzinga
Cannabis Unicorn PharmaCann Could IPO Soon, Valued At $1.1B+
August 16, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|